Zobrazeno 1 - 10
of 250
pro vyhledávání: '"antipsychotic-induced weight gain"'
Publikováno v:
BJPsych Open, Vol 10 (2024)
Background Antipsychotic-induced weight gain (AIWG) is a substantial contributor to high obesity rates in psychiatry. Limited management guidance exists to inform clinical practice, and individuals with experience of managing AIWG have had no or mini
Externí odkaz:
https://doaj.org/article/aa3fdb2176e444d3968bb83b40fc3996
Publikováno v:
Ожирение и метаболизм, Vol 19, Iss 4, Pp 431-441 (2023)
Antipsychotic drugs are widely used for many psychiatric disorders, such as schizophrenia, bipolar affective disorder, delusions and hallucinations due to neurological disorders, depression with severe psychotic symptoms. Metabolic disorders includin
Externí odkaz:
https://doaj.org/article/8d5c5e39f89a4830a62078fa55c6d874
Autor:
Ita Fitzgerald, Laura J. Sahm, Amy Byrne, Jean O’Connell, Joie Ensor, Ciara Ní Dhubhlaing, Sarah O’Dwyer, Erin K. Crowley
Publikováno v:
European Psychiatry, Vol 66 (2023)
Abstract Background Whether non-genetic prognostic factors significantly influence the variable prognosis of antipsychotic-induced weight gain (AIWG) has not yet been systematically explored. Methods Searches for both randomized and non-randomized s
Externí odkaz:
https://doaj.org/article/9b2a3376bbaf477ab4a684996162c20f
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Обозрение психиатрии и медицинской психологии имени В.М. Бехтерева, Vol 55, Iss 1, Pp 3-10 (2021)
Antipsychotic drugs are a critical modality in managing of schizophrenia. Although medications can be highly effective, response varies and some patients derive considerably less benefit than others. Long-term use of antipsychotic drugs is associat
Externí odkaz:
https://doaj.org/article/71720569c73d4b338647c5106a1392ff
Autor:
Nini de Boer, Sinan Guloksuz, Caroline van Baal, Leonie Willebrands, Jeroen Deenik, Christiaan H. Vinkers, Inge Winter-van Rossum, Janneke Zinkstok, Ingeborg Wilting, Jasper B. Zantvoord, Frank Backx, Wilma E. Swildens, Marieke Schouw, Jan Bogers, Folkwin Hulshof, Rudolf de Knijff, Peter Duindam, Mike Veereschild, Maarten Bak, Geert Frederix, Lieuwe de Haan, Jim van Os, Wiepke Cahn, Jurjen J. Luykx
Publikováno v:
BMC Psychiatry, Vol 21, Iss 1, Pp 1-11 (2021)
Abstract Background Antipsychotic-induced Weight Gain (AiWG) is a debilitating and common adverse effect of antipsychotics. AiWG negatively impacts life expectancy, quality of life, treatment adherence, likelihood of developing type-2 diabetes and re
Externí odkaz:
https://doaj.org/article/cf21f7b92b4a4f12ae9ed7e1d9f4014c
Autor:
M. N. Grunina, A. M. Zabotina, A. S. Zhuravlev, M. M. Pchelina, E. V. Volkova, R. F. Nasyrova, A. E. Taraskina, E. M. Krupitsky
Publikováno v:
Учёные записки Санкт-Петербургского государственного медицинского университета им. Акад. И.П. Павлова, Vol 27, Iss 1, Pp 45-56 (2020)
Introduction. Despite the evolution of antipsychotic drugs, the problem of the therapy effectiveness and safety of schizophrenia spectrum disorders and comorbid conditions is very acute. The dopamine receptor D2 gene (DRD2) is one of the key targets
Externí odkaz:
https://doaj.org/article/bbecc772a537442189ea31fb117d1a48
Publikováno v:
Lipids in Health and Disease, Vol 19, Iss 1, Pp 1-12 (2020)
Abstract Antipsychotic-induced weight gain is the most prevalent somatic adverse event occurring in patients treated by antipsychotics, especially atypical antipsychotics. It is of particular interest because of its repercussion on cardiovascular mor
Externí odkaz:
https://doaj.org/article/cd4f8d251178467f865fb0779c469b64
Autor:
Yanisa Wannasuphoprasit, Stig Ejdrup Andersen, Maria J. Arranz, Rosa Catalan, Gesche Jurgens, Sanne Maartje Kloosterboer, Henrik Berg Rasmussen, Anjali Bhat, Haritz Irizar, Dora Koller, Renato Polimanti, Baihan Wang, Eirini Zartaloudi, Isabelle Austin-Zimmerman, Elvira Bramon
Publikováno v:
Frontiers in Psychology, Vol 12 (2022)
BackgroundAntipsychotic-induced weight gain is a contributing factor in the reduced life expectancy reported amongst people with psychotic disorders. CYP2D6 is a liver enzyme involved in the metabolism of many commonly used antipsychotic medications.
Externí odkaz:
https://doaj.org/article/329a6163499a42ae9f34e1da18f61c33
Autor:
Ita Fitzgerald, Sarah O'Dwyer, Margaret Brooks, Laura Sahm, Erin Crowley, Ciara Ní Dhubhlaing
Publikováno v:
Frontiers in Psychiatry, Vol 12 (2021)
Externí odkaz:
https://doaj.org/article/4373fe01333946028c57bab35a46e63b